Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting
– Twenty presentations, including late-breaking, oral and poster presentations, highlight advances across seven of the company’s medicines – Late-breaking data presentation at ASH will feature...